6101 - 6125 of 9140 Results
Title
Year
-
OPENTitle: Reproducibility of a Parkinsonism‐related metabolic brain network in non‐human primates: A descriptive pilot study with FDG PETJournal Name: Movement DisordersPublisher: WileyVol: 30Issue #: 9Start Page: 1283End Page: 1288Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.26302Best OA location URL: http://doi.org/10.1002/mds.26302Citation Count: 18
-
OPENTitle: Peptidoglycan recognition protein genes and risk of Parkinson's diseaseJournal Name: Movement DisordersPublisher: WileyVol: 29Issue #: 9Start Page: 1171End Page: 1180Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.25895Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/4777298Citation Count: 52
-
OPENTitle: Clinimetric testing of the comprehensive cervical dystonia rating scaleJournal Name: Movement DisordersPublisher: WileyVol: 31Issue #: 4Start Page: 563End Page: 569Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.26534Best OA location URL: http://doi.org/10.1002/mds.26534Citation Count: 49
-
RESTRICTEDTitle: Balancing the basal ganglia circuitry: A possible new role for dopamine D2 receptors in health and diseaseJournal Name: Movement DisordersPublisher: WileyVol: 30Issue #: 7Start Page: 895End Page: 903Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.26282Best OA location URL: http://doi.org/10.1002/mds.26282Citation Count: 47
-
RESTRICTEDTitle: Exercise improves cognition in Parkinson's disease: The PRET‐PD randomized, clinical trialJournal Name: Movement DisordersPublisher: WileyVol: 30Issue #: 12Start Page: 1657End Page: 1663Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.26291Best OA location URL: http://doi.org/10.1002/mds.26291Citation Count: 185
-
OPENTitle: Olfactory dysfunction in Parkinson's disease: Positive effect of cigarette smokingJournal Name: Movement DisordersPublisher: WileyVol: 30Issue #: 6Start Page: 859End Page: 862Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.26126Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/4439272Citation Count: 36
- Cortical phosphorylated α‐Synuclein levels correlate with brain wave spectra in Parkinson's disease2016OPENTitle: Cortical phosphorylated α‐Synuclein levels correlate with brain wave spectra in Parkinson's diseaseJournal Name: Movement DisordersPublisher: WileyVol: 31Issue #: 7Start Page: 1012End Page: 1019Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.26621Best OA location URL: http://doi.org/10.1002/mds.26621Citation Count: 37
-
OPENTitle: Intake of antioxidant vitamins and risk of Parkinson's diseaseJournal Name: Movement DisordersPublisher: WileyVol: 31Issue #: 12Start Page: 1909End Page: 1914Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.26819Best OA location URL: http://nrs.harvard.edu/urn-3:HUL.InstRepos:41263027Citation Count: 108
-
RESTRICTEDTitle: A scan without evidence is not evidence of absence: Scans without evidence of dopaminergic deficit in a symptomatic leucine‐rich repeat kinase 2 mutation carrierJournal Name: Movement DisordersPublisher: WileyVol: 31Issue #: 3Start Page: 405End Page: 409Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.26450Best OA location URL: http://doi.org/10.1002/mds.26450Citation Count: 20
-
OPENTitle: Cerebellar ataxia in progressive supranuclear palsy: An autopsy study of PSP‐CJournal Name: Movement DisordersPublisher: WileyVol: 31Issue #: 5Start Page: 653End Page: 662Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.26499Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/4861661Citation Count: 76
-
OPENTitle: MiRNAs shape mouse age-independent tissue adaptation to spaceflight via ECM and developmental pathwaysJournal Name: Nature CommunicationsPublisher: Springer Science and Business Media LLCVol: 17Issue #: 1Start Page: 1387End Page: 1387Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41467-026-68737-1Best OA location URL: https://www.nature.com/articles/s41467-026-68737-1.pdfCitation Count: 0
-
OPENTitle: Self-management for people with epilepsy and a history of negative health events (SMART): A randomized controlled effectiveness trialJournal Name: Epilepsy & BehaviorPublisher: Elsevier BVVol: 171Issue #:Start Page: 110495End Page: 110495Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1016/j.yebeh.2025.110495Best OA location URL: https://www.epilepsybehavior.com/article/S1525-5050(25)00234-3/pdfCitation Count: 5
-
OPENTitle: Genetic Evidence Supporting a Causal Role of Depression in Alzheimer’s DiseaseJournal Name: Biological PsychiatryPublisher: Elsevier BVVol: 92Issue #: 1Start Page: 25End Page: 33Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.biopsych.2021.11.025Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/9200901Citation Count: 68
-
OPENTitle: Movement disorders in non-encephalopathic Hashimoto's thyroiditisJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 55Issue #:Start Page: 141End Page: 142Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2018.06.008Best OA location URL: https://zenodo.org/record/3873759Citation Count: 17
-
OPENTitle: LRRK2 activation in idiopathic Parkinson’s diseaseJournal Name: Science Translational MedicinePublisher: American Association for the Advancement of Science (AAAS)Vol: 10Issue #: 451Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1126/scitranslmed.aar5429Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/6344941Citation Count: 603
-
OPENTitle: Molecular Mechanisms Underlying Synaptic and Axon Degeneration in Parkinson’s DiseaseJournal Name: Frontiers in Cellular NeurosciencePublisher: Frontiers Media SAVol: 15Issue #:Start Page: 626128End Page: 626128Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fncel.2021.626128Best OA location URL: https://www.frontiersin.org/articles/10.3389/fncel.2021.626128/pdfCitation Count: 129
- CoREST Complex-Selective Histone Deacetylase Inhibitors Show Prosynaptic Effects and an Improved Safety Profile To Enable Treatment of Synaptopathies2018RESTRICTEDTitle: CoREST Complex-Selective Histone Deacetylase Inhibitors Show Prosynaptic Effects and an Improved Safety Profile To Enable Treatment of SynaptopathiesJournal Name: ACS Chemical NeurosciencePublisher: American Chemical Society (ACS)Vol: 10Issue #: 3Start Page: 1729End Page: 1743Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1021/acschemneuro.8b00620Citation Count: 49
-
OPENTitle: A Large-Scale Multi-ancestry Genome-wide Study Accounting for Smoking Behavior Identifies Multiple Significant Loci for Blood PressureJournal Name: The American Journal of Human GeneticsPublisher: Elsevier BVVol: 102Issue #: 3Start Page: 375End Page: 400Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.ajhg.2018.01.015Best OA location URL: http://www.cell.com/article/S000292971830017X/pdfCitation Count: 178
-
OPENTitle: Changes in properties of serine 129 phosphorylated α-synuclein with progression of Lewy-type histopathology in human brainsJournal Name: Experimental NeurologyPublisher: Elsevier BVVol: 240Issue #:Start Page: 190End Page: 204Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.expneurol.2012.11.020Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/3720241Citation Count: 152
-
OPENTitle: S-Nitrosylation of PINK1 Attenuates PINK1/Parkin-Dependent Mitophagy in hiPSC-Based Parkinson’s Disease ModelsJournal Name: Cell ReportsPublisher: Elsevier BVVol: 21Issue #: 8Start Page: 2171End Page: 2182Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.celrep.2017.10.068Best OA location URL: http://www.cell.com/article/S2211124717315310/pdfCitation Count: 131
- Phosphorylated α-synuclein-immunoreactive retinal neuronal elements in Parkinson's disease subjects2014RESTRICTEDTitle: Phosphorylated α-synuclein-immunoreactive retinal neuronal elements in Parkinson's disease subjectsJournal Name: Neuroscience LettersPublisher: Elsevier BVVol: 571Issue #:Start Page: 34End Page: 38Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.neulet.2014.04.027Best OA location URL: http://doi.org/10.1016/j.neulet.2014.04.027Citation Count: 141
- Photobiomodulation-induced changes in a monkey model of Parkinson’s disease: changes in tyrosine hydroxylase cells and GDNF expression in the striatum2017RESTRICTEDTitle: Photobiomodulation-induced changes in a monkey model of Parkinson’s disease: changes in tyrosine hydroxylase cells and GDNF expression in the striatumJournal Name: Experimental Brain ResearchPublisher: Springer Science and Business Media LLCVol: 235Issue #: 6Start Page: 1861End Page: 1874Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s00221-017-4937-0Citation Count: 56
-
OPENTitle: L-DOPA functionalized, multi-branched gold nanoparticles as brain-targeted nano-vehiclesJournal Name: Nanomedicine: Nanotechnology, Biology and MedicinePublisher: Elsevier BVVol: 15Issue #: 1Start Page: 1End Page: 11Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.nano.2018.08.011Best OA location URL: http://hdl.handle.net/10044/1/63483Citation Count: 100
-
OPENTitle: Cross-platform comparison of highly sensitive immunoassay technologies for cytokine markers: Platform performance in post-traumatic stress disorder and Parkinson’s diseaseJournal Name: Cytokine: XPublisher: Elsevier BVVol: 2Issue #: 2Start Page: 100027End Page: 100027Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.cytox.2020.100027Best OA location URL: https://doi.org/10.1016/j.cytox.2020.100027Citation Count: 48
- Dopamine-mediated improvements in dynamic balance control in Parkinson’s disease2020RESTRICTEDTitle: Dopamine-mediated improvements in dynamic balance control in Parkinson’s diseaseJournal Name: Gait & PosturePublisher: Elsevier BVVol: 82Issue #:Start Page: 68End Page: 74Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.gaitpost.2020.08.132Citation Count: 12